Brief: Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
07/11/2023 12:35
Nov 7 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS THIRD QUARTER 2023
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SENSEI BIOTHERAPEUTICS INC - STRONG BALANCE SHEET WITH
CASH
RUNWAY INTO SECOND HALF OF 2025
* SENSEI BIOTHERAPEUTICS-PHASE 1/2 TRIAL OF SNS-101
CONTINUES TO
ENROLL AHEAD OF SCHEDULE, WITH NEW CLINICAL DATA MILESTONES
ANTICIPATED THROUGHOUT 2024
Source text for Eikon: ID:nGNX9jRxJ9
Further company coverage: SNSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments